Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer

Código QR

Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer

ObjectiveEmerging evidence showed that immune checkpoint inhibitors (ICIs) lead to hyperprogressive disease (HPD) in a small proportion of patients. There is no well-recognized standard for the evaluation of HPD. Comprehensive exploration of HPD definition system in gastrointestinal cancer treated w...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhenghang Wang, Chang Liu, Yuezong Bai, Xiaochen Zhao, Longgang Cui, Zhi Peng, Xiaotian Zhang, Xicheng Wang, Zhengyi Zhao, Jian Li, Lin Shen
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	hyperprogressive disease gastrointestinal cancer immune checkpoint inhibitors circulating tumor DNA next-generation sequencing Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/dc2063dc3e28419fbe5a61234b8e96fb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer
por: Zhihao Lu, et al.
Publicado: (2021)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
por: Po-Han Lin, et al.
Publicado: (2021)

Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
por: Vasiliki Pisanidou, et al.
Publicado: (2021)

TUMOR ESTROMAL GASTROINTESTINAL (GIST): FORMAS DE PRESENTACION
por: Oyanedel Q,Roberto, et al.
Publicado: (2005)

Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer
por: Jill P. Smith, et al.
Publicado: (2021)

Next-Generation Sequencing Targeted Panel in Routine Care for Metastatic Colon Cancers
por: Arnaud Bayle, et al.
Publicado: (2021)

Advances in gastrointestinal cancers

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer
por: T. Hedley Carr, et al.
Publicado: (2021)

Scope of Artificial Intelligence in Gastrointestinal Oncology
por: Hemant Goyal, et al.
Publicado: (2021)

Gastrointestinal Stromal Tumors (GISTs): Single Center Experience Observed in a Small Series of Cases
por: Manterola,Carlos, et al.
Publicado: (2016)

Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma
por: He Ren, et al.
Publicado: (2021)

Progress of Immune Checkpoint Inhibitors  in the Treatment of Advanced Pulmonary Neuroendocrine Tumors
por: Haoqing CHEN, et al.
Publicado: (2021)

Favorable Response to Olaparib in a Patient with Cancer of Unknown Primary Carrying a Germline BRCA1 R71K Mutation
por: Jia X, et al.
Publicado: (2021)

Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer
por: Minji Lim, et al.
Publicado: (2021)

Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study
por: Satoshi Kawakami, et al.
Publicado: (2021)

Bacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory
por: Sajeen Bahadur Amatya, et al.
Publicado: (2021)

Detection Technology and Prospects of Clinical Application of Circulating Tumor Cells in Pancreatic Cancer
por: YANG Xiaoying, et al.
Publicado: (2021)

Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
por: ZHU Kuikui, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and Biomarkers
por: Brian W. Labadie, et al.
Publicado: (2021)

MANEJO QUIRÚRGICO SIMULTÁNEO DE UNA PACIENTE CON CÁNCER DE PÁNCREAS DISTAL, TUMORES DEL ESTROMA GASTROINTESTINAL (GIST) GÁSTRICOS Y HEMANGIOMA HEPÁTICO
por: Beltrán S,Marcelo A, et al.
Publicado: (2014)

A genomic mutation signature predicts the clinical outcomes of immunotherapy and characterizes immunophenotypes in gastrointestinal cancer
por: Xi Jiao, et al.
Publicado: (2021)

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Nicola Personeni, et al.
Publicado: (2021)

Cytomorphology of Circulating Tumor Cells and Cell Clusters in Chilean Patients with Colo-Rectal Cancer
por: Murray,Nigel P, et al.
Publicado: (2012)

Application of Next-generation Sequencing Detecting Gene Mutation in Myelodysplastic Syndromes: Current Situation and Problems
por: XIAO Zhijian
Publicado: (2021)

SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib
por: Daria A. Filonenko, et al.
Publicado: (2020)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
por: Cor J. Ravensbergen, et al.
Publicado: (2021)

Pharmacogenetic markers of chemotherapy toxicity in gastrointestinal tumors: a preliminary analysis
por: Denis S. Fedorinov, et al.
Publicado: (2021)

Tumores del Estroma Gastrointestinal (GIST): Características Clinico-Morfológicas y Perfil Inmunohistoquímico
por: Tapia E,Oscar, et al.
Publicado: (2011)

Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
por: Robert A. Szczepaniak Sloane, et al.
Publicado: (2021)

Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor
por: Jingjing Wang, et al.
Publicado: (2021)

Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer
por: Rui He, et al.
Publicado: (2021)

Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA
por: Jinyong Huang, et al.
Publicado: (2021)

Functional Peptides Encoded by Long Non-Coding RNAs in Gastrointestinal Cancer
por: Yao Chen, et al.
Publicado: (2021)

Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case
por: Daria A. Filonenko, et al.
Publicado: (2021)

Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
por: Antoine Italiano, et al.
Publicado: (2021)

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events
por: Rilan Bai, et al.
Publicado: (2021)

PAPEL DE LA NUTRICIÓN EN LA PREVENCIÓN DEL CÁNCER GASTROINTESTINAL
por: Pierart Z,Camila, et al.
Publicado: (2006)

A Gastric Metastatic Lesion That Resembled Early-Stage Gastric Cancer on Endoscopy during Treatment for Recurrent Breast Cancer: A Case Report
por: Yukino Watanabe, et al.
Publicado: (2021)

Immune-mediated adverse events in immune checkpoint inhibitors therapy: literature review
por: Marina A. Lyadova, et al.
Publicado: (2021)

Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1
por: Changbo Sun, et al.
Publicado: (2021)